Zelira Therapeutics Ltd has released a press release.
Strategic Transition and Executive Changes
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Story so far
Earlier from Zelira Therapeutics
- December 2020 Quarterly Report
- Zelira Expands HOPE Distribution to Washington DC, USA
- R&D Tax Incentive Refund
- ZLD Partners with SprinJene to Launch CBD Toothpaste in US
- Emyria Deal and Autism Observational Trial for HOPE Products
Later from Zelira Therapeutics
- Appendix 4D & FY21 Interim Financial Report
- Zelira Announces Record Third Quarter Revenue
- March 2021 Quarterly Report
- Zeliras HOPE Range of Products Launches in Washington DC
- ZLD and Levin Health to Conduct Chronic Pain Clinical Trial
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics